Centocor ( CNTO ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Centocor ( CNTO )

CNTO 0.00001000

0.0%

Mar 7 3:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (865)	12/8/1998 4:20:00 PM
From: Douglas Babbin	Read Replies (1) of 965

I spoke w/ someone from investor relations at CNTO today. They attributed the sell off last week to two brokerage firms that lowered the revenue estimates for Remicade. He didn't believe the old Remicade formulation was much of an issue to many investors. In any event, most firms are expecting similar Remicade sales at this point. The other two firms had been overly aggressive.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next